[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363379-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363379-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","revealing-the-cuproptosis-lncrna-nexus-in-gastric-cancer-a-multicohort-observational-study","Revealing the cuproptosis-lncRNA nexus in gastric cancer - A multicohort observational study","","Cuproptosis-related lncRNA signature development and evaluation in gastric cancer is performed using multi-cohort transcriptomic analyses. TCGA and GEO transcriptome data are analyzed with Pearson correlation and LASSO-Cox regression to build a prognostic model, then assessed through Kaplan–Meier survival, time-dependent ROC curves, and decision curve analysis. An mRNA-based RS score is validated in additional GEO datasets and the IMvigor210 cohort. Two key lncRNAs are confirmed via qRT-PCR, and a 25-lncRNA signature stratifies patients into high- and low-risk groups with distinct immune and mitochondrial pathway profiles.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/revealing-the-cuproptosis-lncrna-nexus-in-gastric-cancer-a-multicohort-observational-study/363379/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/revealing-the-cuproptosis-lncrna-nexus-in-gastric-cancer-a-multicohort-observational-study/363379.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal in gastric cancer?","Question",{"text":63,"@type":64},"To establish a cuproptosis-related lncRNA signature and assess its prognostic value, including potential immunological relevance in gastric cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is the prognostic model constructed and evaluated?",{"text":68,"@type":64},"Transcriptomic datasets are analyzed with Pearson correlation and LASSO-Cox regression to build the model, which is evaluated using Kaplan–Meier analysis, time-dependent ROC curves, and decision curve analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What validation is performed for the signature and key lncRNAs?",{"text":72,"@type":64},"The mRNA-based RS score is validated in external GEO datasets and the IMvigor210 cohort, and two key lncRNAs (AC245041.1 and LINC01614) are confirmed by qRT-PCR in an independent gastric cancer cohort.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363379,1790228540,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","®  \n Observational Study   \nRevealing the cuproptosis-lncRNA nexus in gastric cancer  \nA multicohort observational study  \nXin Zhou, MD, PhDa ,b , Jin Liu, MDa , Xiaping Wang, MDc , Yiqing Zhang, BMd , Lan Zhang, MDe , Zicong Jiao, MSf , Xuan Gao, PhDg ,h , Li Liu, MDi , Mingxia Zhu, MDj , Jing He, MD, PhDb , Tongshan Wang, MD, PhDb , Qing Zhang, MDk ,*  \n\n| Abstract\u003Cbr>To establish a cuproptosis-related lncRNA signature and evaluate its prognostic value and potential immunological relevance in gastric cancer (GC) . Transcriptomic data from the cancer genome atlas and gene expression omnibus were analyzed using Pearson correlation and least absolute shrinkage and selection operator Cox regression to construct the prognostic model. Model performance was assessed by Kaplan–Meier analysis, time-dependent receiver operating characteristic curves, and decision curve analysis. An mRNA-based RS score was further validated in Gene Expression Omnibus datasets and the IMvigor210 cohort. Expression of 2 key long noncoding RNAs (AC245041 .1 and LINC01614) was confirmed by qRT-PCR in an independent GC cohort. A 25-lncRNA cuproptosis-related signature effectively stratified patients into high-and low-risk groups, with the highrisk group showing significantly poorer survival. The model outperformed conventional clinical variables. Functional enrichment suggested involvement of immune regulation and mitochondrial pathways related to cuproptosis, and the low-risk group displayed a more immunologically active profile. The RS score showed consistent predictive performance across external cohorts, and qRT-PCR validated the prognostic relevance of AC245041 .1 and LINC01614 . This cuproptosis-related lncRNA signature demonstrates potential as a prognostic indicator and may provide insights into immunotherapy relevance, offering a promising direction for personalized GC management. |\n| --- |\n| Abbreviations: DCA = decision curve analysis, DSS = disease specific survival, GC = gastric cancer, GEO = gene expression omnibus, GO = gene ontology, IPS = immunophenoscore, KEGG = kyoto encyclopedia of genes and genomes, K–M = Kaplan– Meier, lncRNA = long noncoding RNA, MSI = microsatellite instability, OS = overall survival, PFI = progression-free interval, TCGA = the cancer genome atlas, TMB = tumor mutational burden, TME = tumor microenvironment. |\n| Keywords: cuproptosis, gastric cancer, immunotherapy, LncRNAs, prognosis |\n\n1. Introduction  \nGastric cancer (GC) continues to pose a major global health burden, ranking fifth in cancer-related mortality worldwide. [1]  \nOwing to its insidious onset, ~80% of GC patients are diagnosed at advanced stages, leading to poor clinical outcomes. While immunotherapy has revolutionized the treatment landscape for metastatic GC, its effectiveness is limited, with only a  \nXZ, JL, XW, and YZ contributed to this article equally.  \nThis work was supported by Suqian Sci&Tech Program (Grant No. KY202401), the National Natural Science Foundation of China (Grant No. 81702364) and the Natural Science Foundation of Jiangsu Province (Grant number: BK20171085). The authors have no conflicts of interest to disclose.  \nThe datasets generated during and/or analyzed during the current study are publicly available.  \nThis study was approved by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University (2017-SRFA-104), and written informed consent was obtained from all participants.  \nThe data used in this study were derived from both publicly available databases (TCGA and GEO) and our institutional cohort. TCGA and GEO are open-access resources and do not require permission for reuse. The institutional data were collected and used in accordance with ethical approval from our institution. Supplemental Digital Content is available in the online version of this article ([http://](http://)[ ](http://)[dx.doi.org/10.1097/MD.0000000000048729](dx.doi.org/10.1097/MD.0000000000048729)).  \na Department of Oncology, Jiang","cbCaivX4m2TIfvul","https://ap.wps.com/l/cbCaivX4m2TIfvul","pdf",2789438,11,"English","# Abstract\n## Abbreviations\n## Keywords\n# Introduction\n# Methods (implied by abstract)\n## Model construction and validation\n# Results (implied by abstract)\n## Prognostic stratification and survival impact\n## Immune and mitochondrial pathway enrichment\n# Discussion / Implications (implied by abstract)","[{\"question\":\"What is the study’s main goal in gastric cancer?\",\"answer\":\"To establish a cuproptosis-related lncRNA signature and assess its prognostic value, including potential immunological relevance in gastric cancer.\"},{\"question\":\"How is the prognostic model constructed and evaluated?\",\"answer\":\"Transcriptomic datasets are analyzed with Pearson correlation and LASSO-Cox regression to build the model, which is evaluated using Kaplan–Meier analysis, time-dependent ROC curves, and decision curve analysis.\"},{\"question\":\"What validation is performed for the signature and key lncRNAs?\",\"answer\":\"The mRNA-based RS score is validated in external GEO datasets and the IMvigor210 cohort, and two key lncRNAs (AC245041.1 and LINC01614) are confirmed by qRT-PCR in an independent gastric cancer cohort.\"}]","Revealing the cuproptosis-lncRNA nexus in gastric cancer - A multicohort observational study | PDF",1790151003,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5ce16507ae3224b8acf0770e968d0e9.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c656f787abc4f7561a0618c40719fb0.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29327c4078173b0fc6d88cffa4220a71.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a70e090da8a96e9bcd79a197b71e97f.webp",980,1306]